15 employees
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
2003
$30M
from 2 investors over 2 rounds
APEIRON Biologics AG raised undisclosed on May 18, 2020
Investors: Vienna Insurance Group AG Wiener Versicherung Gruppe
APEIRON Biologics AG raised $30M on August 29, 2017
Investors: European Investment Bank